Efg Asset Management (North America) Corp. United Therapeutics Corp Transaction History

Efg Asset Management (North America) Corp.

$585 Million
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	SELL	$212.99 - $276.17 $177,420 - $230,049	-833 Reduced 7.81%	9,831 $2.2 Million
Q4 2022 Feb 03, 2023	SELL	$205.95 - $280.43 $368,032 - $501,128	-1,787 Reduced 14.35%	10,664 $2.97 Million
Q3 2022 Oct 28, 2022	BUY	$203.3 - $244.17 $151,661 - $182,150	746 Added 6.37%	12,451 $2.61 Million
Q2 2022 Aug 04, 2022	BUY	$174.81 - $241.14 $2.05 Million - $2.82 Million	11,705 New	11,705 $2.76 Million

Others Institutions Holding UTHR

# of Institutions

676

Shares Held

42.1M

Call Options Held

194K

Put Options Held

295K

Black Rock Inc. New York, NY

5.47M
Shares

$1.96 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

4.41M
Shares

$1.58 Billion
0.03% of portfolio
Wellington Management Group LLP Boston, MA

3.17M
Shares

$1.14 Billion
0.2% of portfolio
Avoro Capital Advisors LLC New York, NY

2.86M
Shares

$1.03 Billion
15.42% of portfolio
State Street Corp Boston, MA

2.24M
Shares

$803 Million
0.03% of portfolio

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.3B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (North America) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (North America) Corp. with notifications on news.

Account